DUBLIN, March 4, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that Paul Bisaro, Chairman and CEO of Actavis, will provide an overview and update of the Company's business at the Barclays Global Healthcare Conference in Miami.
The presentation will take place on Tuesday, March 11, 2014 at 9:30 AM Eastern Standard Time at the Lowes Miami Hotel, 1601 Collins Avenue, Miami, FL. To access a live webcast of the presentation, visit Actavis' Investor Relations Web site at http://ir.actavis.com. The webcast can also be accessed at the following URL:
An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.
Actavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Actavis has global headquarters in Dublin, Ireland and U.S. administrative headquarters in Parsippany, New Jersey, USA.
Actavis develops and manufactures generic, brand, branded generic, legacy brands and Over-the-Counter (OTC) pharmaceutical products and has commercial operations in approximately 60 countries. The Company's North American branded pharmaceuticals business is focused principally in the Women's Health, Urology, Gastroenterology and Dermatology therapeutic categories with a strong pipeline of products in various stages of development. Actavis also has a portfolio of five biosimilar products in development in Women's Health and Oncology. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.
For press release and other company information, visit Actavis' Web site at http://www.actavis.com
SOURCE Actavis plc